This site is dedicated to (the small number of) Osteosarcoma patients, doctors and researchers, all over the world.
It’s goal is to provide reliable, up to date information about the best treatments and the most promising research.
Osteosarcoma is one among more than a hundred related diseases classified under the name cancer. Because Osteosarcoma is a very rare form of cancer (four children in one million and only one adult in one million get primary bone cancer,) it does not receive adequate funding. (In 2007 osteosarcoma research received only 37.1 million dollars. The cost of ONE Lockeed F-117A jet fighter was $45 million.)
Less than 3 percent of federal cancer research funding goes to pediatric cancer and a child in the United States has a one in 320 chance of being diagnosed with cancer.
Even more compelling, cancer treatment is more expensive and less available in America than any other first world country. Most countries regulate drug prices and profits but the United States allows companies to charge whatever the market will bear. Since the bottom 80% of Americans control only about 15% of the wealth and the bottom 40% control less than 1% ( Income and Wealth Distribution in America ) and the top 1% control almost 40%, it isn’t difficult to understand why. Many studies have shown that scientific progress does not improve with extreme financial incentives but, in fact, the opposite is the case. See:
The Financing of Scientific Journals should be investigated by Congress
NOTE: I will also publish interesting articles about other major forms of cancer because there is so little research on Osteosarcoma. It is my belief that some of the therapies that are effective against any cancer have the potential for being effective against Osteosarcoma and other cancers as well.